Vanguard Asset Management
HALO icon

Vanguard Asset Management’s Halozyme HALO Stock Holding History

Vanguard Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.89M Buy
113,615
+5,117
+5% +$349K 0.01% 765
2026
Q1 		$7.01M Buy
+108,498
New +$7.65M 0.01% 784

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Asset Management's HALO Position: Q2 2026 in Review

Vanguard Asset Management increased its Halozyme (HALO) stake by 4.7% in Q2 2026, buying an estimated $349K and bringing the position to 113,615 shares worth $8.89M. The position accounts for 0.01% of the portfolio, ranked #765.

Vanguard Asset Management first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 651 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Vanguard Asset Management held 113,615 shares of Halozyme worth $8.89M as of Q2 2026.
  • Vanguard Asset Management bought 5,117 Halozyme shares in Q2 2026, an estimated $349K.
  • Halozyme made up 0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #765 holding.
  • Vanguard Asset Management first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 651 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.